Harte-Hanks Inc risk profile
59 Elevated one input has moved against it
Measured 21 October 2026 from HHS's filed statements. Recomputed nightly.
59 (Elevated), driven by Concentration at 89, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 52 | Elevated | Volatile | One-year price volatility — 76.8% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 87 | Acute | Stable | Capital spending against operating cash — -1.59x |
| Leverage and coverage | 47 | Elevated | Worsening | Net debt to EBITDA — 3.46x |
| Competitive position | 68 | Stretched | Stable | Revenue-growth gap against peers — -33.4 percentage points |
| Concentration | 89 | Acute | Stable | Geographic concentration — 8,182 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.